Skip to search.
 TSX Up 0.47% TSX Ventures Up 0.38%

Biogen Inc. (BIIB)

-NasdaqGS
304.21 Up 11.71(4.00%) Sep 2, 4:00PM EDT
|After Hours : 304.25 Up 0.04 (0.01%) Sep 2, 7:42PM EDT
Add to Portfolio
Prev Close:292.50
Open:298.48
Bid:303.51 x 300
Ask:305.50 x 1100
1y Target Est:389.94
Beta:0.594625
Earnings Date:Oct 20 - Oct 26 (Est.)
Day's Range:293.61 - 304.43
52wk Range:265.00 - 480.18
Volume:2,271,640
Avg Vol (3m):2,349,650
Market Cap:71.54B
P/E (ttm):20.60
EPS (ttm):14.76
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
BIIBUp 4.00%71.54B
ABTUp 1.54%65.94B
PFEUp 1.95%197.17B

Key Statistics

Forward P/E (1 yr):17.11
P/S (ttm):6.68
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :15.91
Quarterly EPS Est (Sep-15) :3.91
Mean Recommendation*:2.1
PEG Ratio (5 yr expected):1.17

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Biogen Inc. discovers, develops, manufactures, and markets therapies for the treatment of neurological, autoimmune, and hematologic disorders in the United States and internationally. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback